These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34004052)

  • 1. Rhabdomyosarcoma with epithelioid morphology: A challenging cytologic diagnosis in a pleural effusion.
    Rodgers S; Datta L; Perry KD; Stone CH
    Diagn Cytopathol; 2021 Sep; 49(9):E356-E359. PubMed ID: 34004052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma.
    Jo VY; Mariño-Enríquez A; Fletcher CD
    Am J Surg Pathol; 2011 Oct; 35(10):1523-30. PubMed ID: 21921782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
    Folpe AL; McKenney JK; Bridge JA; Weiss SW
    Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effusion cytology of epithelioid rhabdomyosarcoma.
    Renshaw AA; Gould EW
    Diagn Cytopathol; 2019 Oct; 47(10):1042-1044. PubMed ID: 31017725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
    Rekhi B; Dodd L; Dharavath B; Dutt A
    Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic evaluation of metastatic rhabdomyosarcoma in effusion specimens.
    Alderman MA; Thomas DG; Roh MH
    Diagn Cytopathol; 2013 Nov; 41(11):955-9. PubMed ID: 23584957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelioid rhabdomyosarcoma: Report of the first case in the jaw.
    de Aguiar MCF; de Noronha MS; Silveira RL; Araújo JAD; Werkema FS; Bell D; Caldeira PC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):e308-e315. PubMed ID: 32173396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant melanotic nerve sheath tumor in pleural effusion: Deceitful cytology with significant repercussions.
    Jackson C; Linos K; Liu X
    Diagn Cytopathol; 2022 Mar; 50(3):E76-E80. PubMed ID: 34698454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study.
    Zin A; Bertorelle R; Dall'Igna P; Manzitti C; Gambini C; Bisogno G; Rosolen A; Alaggio R
    Am J Surg Pathol; 2014 Feb; 38(2):273-8. PubMed ID: 24418861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelioid Rhabdomyosarcoma; a case report with immunohistochemical and molecular study.
    Jokoji R; Ikeda J; Tsujimoto M; Morii E
    Diagn Pathol; 2015 Jul; 10():124. PubMed ID: 26208724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
    Rekhi B; Upadhyay P; Ramteke MP; Dutt A
    Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.
    Morotti RA; Nicol KK; Parham DM; Teot LA; Moore J; Hayes J; Meyer W; Qualman SJ;
    Am J Surg Pathol; 2006 Aug; 30(8):962-8. PubMed ID: 16861966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma.
    Dehner CA; Geiersbach K; Rowsey R; Murugan P; Broski SM; Meis JM; Rosenberg AE; Folpe AL
    Mod Pathol; 2023 Jun; 36(6):100131. PubMed ID: 36966552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rhabdomyosarcomas: structural distribution and analysis of an immunohistochemical profile].
    Botiralieva GK; Sharlai AS; Roshchin VY; Sidorov IV; Konovalov DM
    Arkh Patol; 2020; 82(5):33-41. PubMed ID: 33054030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft Tissue Special Issue: Skeletal Muscle Tumors: A Clinicopathological Review.
    Kohashi K; Kinoshita I; Oda Y
    Head Neck Pathol; 2020 Mar; 14(1):12-20. PubMed ID: 31950473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous epithelioid rhabdomyosarcoma: a rare, recently described entity with review of the literature.
    Feasel PC; Marburger TB; Billings SD
    J Cutan Pathol; 2014 Jul; 41(7):588-91. PubMed ID: 24628673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.
    Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Furihata M; Ohtsuki Y
    Int J Oncol; 2000 Jul; 17(1):119-25. PubMed ID: 10853028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of New Monoclonal Anti-MyoD1 (MX049) for the Diagnosis of Rhabdomyosarcoma: Comparison with 5.8A, EP212, Anti-Desmin, Anti-Myogenin, and Fluorescence
    He Y; Chen X; Yu X
    Ann Clin Lab Sci; 2020 May; 50(3):412-416. PubMed ID: 32581037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.